AMCP is working with health care stakeholders to overcome challenges and enhance the integration of Real-World Evidence (RWE) into health care decision-making through this initiative.
This initiative brings together individuals widely recognized as experts in RWE due to their contributions to the field, their leadership in research, or their influence in shaping RWE methodologies and policies and organizations at the forefront of advancing the use of RWE in health care, including:
- Health plans
- Integrated Delivery Networks (IDN)
- Pharmacy Benefit Managers (PBM)
- RWE experts
Together, we will provide essential thought leadership, create RWE standards for managed care, integrate these standards into the AMCP format, and provide education and practical application on how to use the RWE standards in evaluating formulary access.
The work with span two years with multiple touch points for health care stakeholders. If you want to learn more or interested in the project, let us know.
Upcoming Events
Nexus 2024: Improving Quality Measure Performance: Real-World Insights from a Pharmacist-Led, Collaborative, Clinical Program
October 15, 2024, Las Vegas, Nevada
This session will aim to provide insights that empower plans to design pharmacist-led clinical programs to improve performance at the measure level. Additionally, this session will include the results of a high-touch and collaborative clinical partnership for the statin use measures that provide the strategic framework for success in other quality measures.
Partnership Forum – Closing the Gap in Real-World Evidence Use: A Collaborative Approach for Health Care Transformation
November 12-13, 2024
This Partnership Forum will convene multi-stakeholder experts to develop resources that will address barriers to RWE use in formulary decision-making through workshop and collaborative activities that will result in a set of RWE standards and tools to facilitate stakeholder communication and streamline the use of RWE.
